InsiderTrades.com logo
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

PER Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$38,875.00
Insider Selling (Last 12 Months): A$0.00

Percheron Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Percheron Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Percheron Therapeutics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 11/19/2024 11:10 AM ET

This chart shows the closing price history over time for PER up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

Percheron Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/27/2024James GarnerInsiderBuy125,000A$0.07A$8,875.00
11/14/2024James GarnerInsiderBuy375,000A$0.08A$30,000.00
See Full Table
Most People Are Dead Wrong.
From Brownstone Research   |   Ad
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.
I call it my AI Retirement Playbook. I recommend you check it out now.

SEC Filings (Institutional Ownership Changes) for Percheron Therapeutics (ASX:PER)

Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Read More on Percheron Therapeutics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Percheron Therapeutics?

Percheron Therapeutics' top insider shareholders include:
  1. James Garner (Insider)
Learn More about top insider investors at Percheron Therapeutics.
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.